Chemoprevention of prostate cancer: The prostate cancer prevention trial
- 1 November 1997
- journal article
- clinical trial
- Published by Wiley in The Prostate
- Vol. 33 (3) , 217-221
- https://doi.org/10.1002/(sici)1097-0045(19971101)33:3<217::aid-pros11>3.0.co;2-n
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Association of Prostate Cancer Risk With Genetic Polymorphisms in Vitamin D Receptor and Androgen ReceptorJNCI Journal of the National Cancer Institute, 1997
- Declining cancer mortality in the United StatesCancer, 1996
- Prostate-specific antigen nadir: the optimum level after irradiation for prostate cancer.Journal of Clinical Oncology, 1996
- Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.Journal of Clinical Oncology, 1996
- The preventive role of diet in prostatic diseasePublished by Wiley ,1996
- Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patientsThe Lancet, 1995
- Intermittent androgen suppression in the treatment of prostate cancer: A preliminary reportUrology, 1995
- Vitamin D and Prostate CancerPublished by Springer Nature ,1995
- A Prospective Study of Dietary Fat and Risk of Prostate CancerJNCI Journal of the National Cancer Institute, 1993
- Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiationCancer, 1992